Suppressors of cytokine signaling (SOCS) are negative regulators of cytokine-induced signal transduction, which play multiple roles in cell growth, differentiation and apoptosis. In this study, the regulatory role of SOCS in oxidative stress-induced apoptosis was investigated. In Jurkat T cells and mouse splenocytes, we have found that SOCS1 is induced in response to tumor necrosis factor-a or H 2 O 2 , concomitant with the activation of Jaks which act as important mediators of reactive oxygen species (ROS)-induced apoptosis upstream of p38 mitogenactivated protein kinase. Using SOCS1 overexpressing or knockdown Jurkat T-cell systems we clearly demonstrate that, SOCS1 inhibits the ROS-mediated apoptosis. The antiapoptotic action of SOCS1 was exerted not only by suppressing Jaks, but also by sustaining protein tyrosine phosphatase (PTP) activities. Notably, SOCS1-transduced cells displayed increase in thioredoxin levels and decrease in ROS generation induced by oxidative stress. In addition, the Jak-inhibiting and PTP-sustaining effect of SOCS1 was significantly reduced on thioredoxin ablation. Moreover, coimmunoprecipitation data revealed molecular interaction of SHP1 or CD45 with thioredoxin, which was promoted in SOCS1-transfected cells. Together, our data strongly suggest that both the protection of PTPs by thioredoxin from ROS attack and the attenuation of Jaks account for the antiapoptotic function of SOCS1 in immune cells under oxidative stress.
Introduction
Reactive oxygen species (ROS), such as superoxide anions (O 2 À ), hydrogen peroxide (H 2 O 2 ) and hydroxyl radicals (OH ) routinely generated within cells as byproducts of mitochondrial respiration, affect diverse aspects of cellular metabolism (Nakamura et al., 1997) . In immune scenarios, ROS are produced and secreted by activated neutrophils and macrophages via NADPH oxidation at inflammation sites, which often provide oxidative microenvironment for T cells (Fialkow et al., 1993; Dang et al., 2006) . In addition, macrophage derived inflammatory cytokines such as tumor necrosis factor (TNF)-a induces ROS generation in target cells (Sparwasser et al., 1997; Odaka et al., 2003) . Both the exogenous and endogenously produced H 2 O 2 as such are known to affect T-cell functions including gene activation, proliferation and apoptosis by regulating the cellular redox status and/or influencing ROS-regulated proteins including protein tyrosine phosphatases (PTPs) and mitogen-activated protein kinases (MAPKs; Devadas et al., 2002; Reth, 2002; Rusanescu et al., 2005) .
All PTPs contain catalytic cysteine residues on the ROS-sensitive site, and the ROS-mediated oxidation of cysteine residues results in their inactivation. These phenomena are reversible during the redox regulation such that the oxidized PTPs are readily reduced back by thioredoxin and/or glutathione, which act in the ROSscavenging system (Nordberg and Arner, 2001) . In this regard, it has been suggested that thioredoxin participates in cell protection from the ROS-induced apoptosis in mammalian systems (Didier et al., 2001) . In addition to the modulation of PTPs, the mechanisms of ROS-induced apoptosis involve diverse downstream enzymes including MAPKs and the associated signaling pathways. For example, H 2 O 2 induces the activation of distinct members of the MAPKs, such as Erk, Jnk and p38 in diverse cell types (Pearson et al., 2001) . However, the precise role that different MAPK members play during ROS-induced apoptosis and the mechanistic link between ROS-mediated modulation of PTPs and MAPK activation are not known. Similarly, although the activation of Jak/Stat components by oxidizing agents has been reported in several cell systems (Cao et al., 2004) , their role in the ROSinduced apoptosis pathway has not been clearly defined and the regulatory factors involved in this process are yet to be explored.
Suppressors of cytokine signaling (SOCS) family proteins were initially identified as negative feedback regulators of Jak/Stat pathways, for which eight distinct members (SOCS1B7 and CIS) are known (Endo et al., 1997; Alexander, 2002) . It has been reported that SOCS suppress cytokine signal transduction by binding to phosphorylated tyrosine residues on cytokine receptor chains and the receptor-associated tyrosine phosphorylated Jaks via the SH2 domain. The binding results in switching off Jaks by acting pseudosubstrates and recruiting ubiquitination machinery via the SOCS-box domain (Yasukawa et al., 1999) . SOCS1 is induced by various cytokines including interferon (IFN)-g, interleukin-4, TNF-a, as well as growth hormones, and downregulates the signals induced by these cytokines in a feedback loop. However, recent studies have indicated that SOCS1 plays diverse roles in cell growth, differentiation, innate immunity, inflammation and apoptosis (Kinjyo et al., 2002; Kubo et al., 2003; He et al., 2006) . For example, SOCS1 may suppress the development and/or progression of hepatocellular carcinoma and hematopoietic malignancies (Yoshida et al., 2004) . Conversely, an apoptosis-inhibitory function of SOCS1 has been also described. In this role, SOCS1 suppresses the apoptosis-inducing effect of TNF-a in L929 fibroblasts (Morita et al., 2000) and Jurkat T cells (Kimura et al., 2004) . The inhibition of TNF-a-induced Jak1 activity has been proposed as mechanism by which SOCS1 attenuates TNF-a-mediated apoptosis of Jurkat T cells (Kimura et al., 2004) . SOCS1 has been shown to regulate the sensitivity of pancreatic islet cells toward the TNF-a-induced cytotoxicity mediated by p38 MAPK (Chong et al., 2002) . In addition, SOCS1 may act as a modulator of apoptosis to ensure controlled survival and apoptosis during pregnancy and involution, respectively (Kubo et al., 2003) .
These findings suggest that SOCS1 functions as a regulator of apoptosis and immune homeostasis. As ROS is known to act as an important mediator of apoptosis during immune inflammatory responses, this study was conducted to establish the regulatory role of SOCS1 in immune cell apoptosis induced by oxidative stress and to investigate the associated signaling mechanisms. The results of this study indicate that Jaks act as an important upstream activator of p38 MAPK during ROS-induced T-cell apoptosis, and that SOCS1 regulates this process by sustaining PTP activities and attenuating Jaks. Furthermore, our data demonstrate that the antiapoptotic function of SOCS1 is manifest via ROS signal regulation involving the PTP-thioredoxin system in immune cells.
Results

Antiapoptotic functions of SOCS1 in immune cells against ROS-mediated cell death
To investigate the role of SOCS in the apoptosis signaling in immune cells, we first analysed the changes in SOCS expression levels induced by various apoptosisinducing agents in a human T cell line Jurkat. IFN-g, TNF-a, dexamethasone and H 2 O 2 caused a significant increase in SOCS1 levels (2-3 fold within 1 h; Supplementary Figure S1A -C). Induction of SOCS1 and SOCS3 expression was also noted in mouse splenocytes in dose-and time-dependent manners by H 2 O 2 (Supplementary Figure S1D and E). Next, to investigate the role of SOCS1 in the regulation of apoptosis induced by oxidative stress, we have established Jurkat T cell lines stably overexpressing SOCS1 (Jurkat/HA-SOCS1), and examined the effect of SOCS1 on the apoptosis induced by TNF-a and H 2 O 2 . TNF-a was chosen because, as an inflammatory and cytotoxic cytokine, its ROS-generating and apoptosis-inducing effects were reported (Odaka et al., 2003) .
Indeed, similar to the case of H 2 O 2 , TNF-a treatment induced a prominent apoptosis (apoptotic populations: 36% for treatment vs 12% for control; Figure 1a ) with an increase in intracellular ROS levels by 2-3 fold within 0.15 h in the control Jurkat cell line (Figure 1b) . However, in SOCS1 overexpressing cells, ROS generation was significantly reduced with a concomitant inhibition of apoptosis induced by TNF-a or H 2 O 2 (B40% inhibition; Figures 1a and b) . The pretreatment of N-acetyl-L-cysteine (NAC), a general ROS inhibitor, resulted in a substantial inhibition of TNF-a-induced ROS generation (Figure 1c ), accompanied by a partial abrogation of H 2 O 2 -as well as TNF-a-induced apoptosis in control cells whereas no further inhibitory effect of NAC on the apoptosis was noted in HA-SOCS1 cells (Figures 1d and e) . The result suggests that both TNF-aand H 2 O 2 -induced apoptosis is mediated by ROS and that an ROS-scavenging effect of SOCS1 is involved in its antiapoptotic function.
Although the protective effect of SOCS1 from cell death induced by H 2 O 2 was seen from 8 to 24 h (Supplementary Figure S2A) , the apoptotic (Annexin V þ /PI À ) rather than necrotic (Annexin V À /PI þ ) populations were mainly reduced by SOCS1 (31.2-11.8%; Figure 1f ). Consistent with this observation, a significant reduction of caspase 3 activity in HA-SOCS1 cells was shown by immunofluorescence staining (Supplementary Figure S2B) , activity assay (Supplementary Figure S2C) and immunoblotting ( Figure 1g ). The H 2 O 2 -induced cell death was accompanied with disruption of mitochondrial membrane potential, permeability change by increased Bax expression and release of cytochrome c, which represents a typical apoptotic features involving mitochondrial dysfunction (Han et al., 2008; Jeong and Seol, 2008) . All of these features were substantially reduced in SOCS1 overexpressing cells (Supplementary Figure  S2D and E). These data collectively suggest that SOCS1 exhibits an antiapoptotic function in T cells under oxidative stress.
Deficiency of SOCS1 promotes ROS-mediated Jurkat T-cell apoptosis To confirm the antiapoptotic role of SOCS1 in the ROSmediated apoptosis, we have also generated SOCS1 knockdown Jurkat T cell lines using two siRNA (si-S1a, si-S1b) or shRNA constructs of SOCS1. The H 2 O 2 -induced apoptotic response was increased by approximately twofold in SOCS1 knockdown cells as compared to the siRNA-negative (Figures 2a and b) or shRNAnegative control (Figures 2c and d) . Specifically, there was a notable increase in cleaved caspase 3 and PARP levels in SOCS1 knockdown cells (Figure 2e ). These findings clearly indicate that SOCS1 plays an important role in the survival response against apoptosis mediated by ROS.
Analysis of Jak/Stat signaling pathways during the ROS-induced apoptosis To examine if the action of SOCS1 in the suppression of ROS-induced apoptosis is mediated by the regulation of Jaks, we assessed the Jak activation profiles under oxidative stress. The kinetic analysis revealed that tyrosine phosphorylation of Jak1 and Jak2 was clearly increased (by 1.7-3.7 fold) in response to H 2 O 2 in 15-30 min. Notably, the H 2 O 2 -induced increases in phospho-Jak1 and phospho-Jak2 levels were nearly abrogated by 30 min in SOCS1 overexpressing cells (Figure 3a) .
The changes in phospho-Stat levels induced by H 2 O 2 were more diverse. An early prominent increase in Stat3 phosphorylation and a delayed increase in Stat1 phosphorylation induced by H 2 O 2 were noted, both of which were drastically suppressed in SOCS1 overexpressing cells. Less prominent upregulation was induced for phosphorylation of Stat2 and Stat5 by H 2 O 2 , which was not negatively affected on SOCS1 overexpression. On the other hand, the phosphorylation of Stat4 and Stat6 was not appreciably changed during the H 2 O 2 -induced apoptosis (Supplementary Figure S3) . Jurkat/mock cells were pretreated with 1 mM N-acetyl-L-cysteine (NAC) for 1 h, and then cells were stimulated with CHX plus TNF-a for 10 or 30 min. ROS generation was measured by flow cytometry using 5 mM DCF-DA. The histograms shown are representative of three independent experiments. (d) Stable cells (mock or HA-SOCS1) were pretreated with 1 mM NAC for 1 h, after which they were incubated with CHX plus TNF-a for 8 h. The numbers of apoptotic cells were measured by FACS. Representative histograms are shown. (e) Stable cells were pretreated with NAC for 1 h, after which they were stimulated with 50 mM H 2 O 2 for 8 h. (f) Jurkat T cells with stable overexpression of SOCS1 or mock vector were either untreated or treated with H 2 O 2 for 6 or 12 h. Both early apoptotic (Annexin V-positive, PI-negative) and late apoptotic (Annexin V-positive and PI-positive) cells were then measured by FACS. (g) Stable cells were treated with DW or H 2 O 2 for 8 h. Whole cell lysates were then prepared and assessed by western blot analysis using specific antibodies against cleaved PARP (89 kDa), cleaved caspase 3 (19/17 kDa), pro-caspase 9 (47 kDa), pro-caspase 2 (48 kDa) and SOCS1 (24 kDa). Actin was used as a loading control.
An increase in phosphorylation of Jak1 (by 2.5 fold) was also induced on TNF-a treatment under ROSmediated apoptotic conditions, which was attenuated in SOCS1 overexpressing cells. The phospho-p38 level was also similarly upregulated by TNF-a, which was again downregulated in SOCS1-transduced cells (Figure 3b ). There was, however, no change in inhibitor kB levels by SOCS1 during the apoptotic conditions induced by TNF-a as reported (Kimura et al., 2004) . In mouse splenocytes, as in the case for Jurkat T cell lines, a similar activation (2-2.5 fold) was observed for Jaks in response to H 2 O 2 and TNF-a within 0.5 h, which was followed by p38 activation (Figures 3c and d) . Noticeably, the negating effect of NAC on the TNF-a-induced Jak1 and p38 activities supports that the activation of Jak1 and p38 induced by TNF-a is mediated by generation of ROS ( Figure 3e ). Together, these data indicate that Jaks and p38 serve as important signaling molecules during the ROS-induced immune cell apoptosis.
Role of Jaks in p38 activation in ROS-induced apoptosis and regulatory function of SOCS1
The H 2 O 2 -induced response is shown to be accompanied with the activation of MAPKs such as Erk, p38, and/or Jnk in various cell types (Pearson et al., 2001; Cao et al., 2004) . We have observed that in Jurkat T-cell systems overexpressing SOCS1, the H 2 O 2 -induced phosphorylation of p38 decreased at 0.5-1 h, whereas Jnk phosphorylation increased at 1 h (Supplementary Figure S4A) . In SOCS1 knockdown cells, by contrast, p38 phosphorylation was enhanced whereas Jnk phosphorylation was reduced (Supplementary Figure S4B) . Moreover, the H 2 O 2 -induced apoptosis was decreased by SB203580 (p38 inhibitor) and increased by SP600125 (Jnk inhibitor) in mock cells. In cells overexpressing SOCS1, SP600125 still promoted apoptosis, whereas SB203580 exhibited no additional inhibition on the apoptosis (Supplementary Figure S4C) . These data suggest that p38 and Jnk each participates in apoptotic and cell survival pathway, respectively, on oxidative stress and that SOCS1 exerts antiapoptotic effect by suppressing p38 activation.
As an upstream activator regulating p38, the role of Jaks was evaluated employing both inhibitor treatment and gene knockdown. It is shown that pretreatment of Jurkat cells with AG490 a Jak inhibitor caused, along with suppression of Jak activation induced by H 2 O 2 , a corresponding inhibition of the early activation of p38 at 30 min ( Figure 4a ). AG490 suppressed the H 2 O 2 -induced apoptosis in mock-transfected cells, and additional antiapoptotic effects of the drug were not seen in SOCS1 overexpressing cells (Figure 4b ). The p38 activity was significantly downregulated on Jak1 or Jak2 knockdown as on overexpression of SOCS1 (Figure 4c ). Likewise, Jak1 or Jak2 knockdown caused a 30-38% suppression of the H 2 O 2 -induced apoptosis in mock cells, and no additional inhibition was achieved in cells overexpressing SOCS1 (Figure 4d ). These results indicate that Jaks are essential for the H 2 O 2 -induced apoptosis via p38 activity regulation, and that the antiapoptotic effect of SOCS1 is likely exerted by the inhibition of Jak function acting upstream of p38. (a) Jurkat/mock or Jurkat/HA-SOCS1 cells were either untreated or treated with H 2 O 2 as described in Figure 1 for the times indicated. The cells were then lysed, after which western blot analysis was performed using specific antibodies to analyse the activation of the Jaks. The band intensity of phospho-Jaks blots was normalized by control Jaks, and data are shown as mean±s.e. obtained from three independent experiments. A representative immunoblot is shown. (b) Stable Jurkat T cells received TNF-a treatment for the indicated times, and cells were analysed by western blotting using specific antibodies against p-Jak1, Jak1, p-p38, p38 and inhibitor kB (IkB). The band intensity of phospho-Jak1 or phospho-p38 was normalized by control Jak1 or p38. Data are shown as mean ± s.e. from multiple blots. (c and d) Isolated mouse splenocytes were stimulated with H 2 O 2 or TNF-a for the times indicated. The cells were subjected to immunoblotting to analyse the activation of Jak1, Jak2, p38 and caspase 3 as well as suppressors of cytokine signaling (SOCS) expression levels. Data are expressed as in panel (a) . (e) Jurkat/mock cells were pretreated with or without N-acetyl-L-cysteine (NAC), after which they were incubated with cycloheximide (CHX) plus TNF-a for the indicated times as described. The cell lysate were prepared and then analysed by western blotting. The band intensity of phospho-Jak1 or phospho-p38 blots was normalized by control Jak1 or p38 as in panel b.
SOCS1 protects PTPs from ROS-mediated inactivation induced by H 2 O 2 or TNF-a Jak activation is achieved through transphosphorylation of catalytic tyrosine residues and is subject to inactivation through dephosphorylation by PTPs (Cuncic et al., 1999; Irie-Sasaki et al., 2001) . As PTP inactivation by ROS is known to occur under oxidative stress, we investigated the role of specific PTPs in the H 2 O 2 -induced apoptosis via regulation of Jaks. In Jurkat T cells, the knockdown of CD45 or SHP1 resulted in a significant promotion of H 2 O 2 -induced apoptosis (Figure 5a ). The enhanced apoptosis of PTP-ablated cells correlated well with increased levels of phosphoJak1 and phospho-Jak2, together with phospho-p38 on H 2 O 2 stimulation (Figure 5b ), which indicates that PTPs play a critical role in the ROS-induced apoptosis by the regulation of Jaks and p38. Although Jaks were modestly activated on PTP knockdown in the absence of ROS, this did not lead to the prominent increase in spontaneous apoptosis or p38 activation (Figures 5a and b) .
It thus seems that PTP/Jak-regulated p38 activation is more evident in cells under oxidative stress than control cells.
Next, we examined the effect of SOCS1 on the regulation of PTP activities under oxidative stress by conducting PTP assays. We found that endogenous CD45 or SHP1 activities were inhibited by 50-60% on H 2 O 2 or TNF-a treatment, and that the inhibition was significantly reduced in SOCS1-transfected cells (Figures  5a-d) . Such restoration of PTP activities in SOCS1-transduced cells was not associated with the changes in expression levels of PTPs as similar levels of PTPs were observed in HA-SOCS1 cells and mock cells (Figures 5e  and f) . In addition, the TNF-a-induced PTP inactivation was restored by NAC pretreatment in mocktransfected cells up to the same level found in HA-SOCS1 cells (Figure 5g ). Thus the data suggest that SOCS1 acts as a potential regulator of PTP activity to control ROS-mediated apoptosis induced by TNF-a or H 2 O 2 . (a) Jurkat T cells were treated with H 2 O 2 in the presence of Jak inhibitor AG490 (10 mM; Calbiochem, San Diego, CA, USA) for the indicated times. Phosphorylation of Jak and p38 as well as the PARP cleavage were then analysed by immunoblotting. The band intensity of phospho-Jak1 or phospho-p38 was normalized by control Jak1 or p38, and data are expressed as mean ± s.e. from three independent blots. (b) Jurkat T cells were pretreated with Jak inhibitor AG490 (10 mM) and PKC-a inhibitor Go¨6090 (1 or 5 mM; Calbiochem) and exposed to H 2 O 2 . After 8 h of incubation, apoptosis was measured by Annexin V staining. (c) Stably established mock or HA-SOCS1 cells were transiently transfected with siRNA-negative control (si), siRNA Jak1 (siJ1) or siRNA Jak2 (siJ2) as described in the Materials and methods section. Twenty-four hours after transfection, the cells were treated with or without H 2 O 2 for 30 min or 4 h. Whole cell extracts were then prepared and analysed for Jak and p38 phosphorylation by immunoblotting. The band intensity of phospho-p38 blots was normalized by control p38 and expressed as mean ± s.e. from three independent blots. 
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Role of thioredoxin in ROS-mediated apoptosis in SOCS1 overexpressing cells As inferred from the data in Figure 1 , SOCS1 inhibition of the H 2 O 2 -or TNF-a-induced apoptotic response involves the regulation of ROS levels. Thus, we have investigated the possibility that antiapoptotic and ROSreducing effect of SOCS1 is mediated via regulation of enzymes of the ROS-scavenging system such as thioredoxin. Indeed, we have found that although thioredoxin expression is induced by H 2 O 2 or TNF-a, its levels were further upregulated in SOCS1 overexpressing cells whereas downregulated in SOCS1 knockdown cells (Figures 6a and b) . The mRNA levels of thioredoxin were also increased in SOCS1 overexpressing cells (Supplementary Figure S5A) . In accordance with the redox regulation of thioredoxin function, ROS levels increased on H 2 O 2 treatment was significantly downregulated in thioredoxin overexpressing cells as in the SOCS1-transfected cells (Supplementary Figure S5B) . Although the transfection of thioredoxin or SOCS1 each protected cells from the ROS-induced apoptosis, SOCSl-mediated antiapoptotic function is substantially reduced in thioredoxin knockdown cells as compared to shRNA control cells (50 vs 34%; Figures 6c and d) . In addition, the ROS-mediated Jak and p38 MAPK activities attenuated in SOCS1-transduced cells were After 2 h, the beads incubated with the PTP assay buffer supplemented with 20 mM p-nitrophenyl phosphate (pNPP) at 37 1C for 30 min. To assay the release of free phosphate, the production of p-nitrophenol was measured colorimetrically at 410 nm. (d) Stable cells were treated with H 2 O 2 for 10 min. When using tyrosine phosphopeptide as substrates; the beads were incubated with 250 mM tyrosine phosphopeptide at 37 1C for 30 min. The immunocomplex was then incubated with 100 ml of malachite green solution for 15 min to release free phosphate, and the absorbance was measured at 620 nm. The PTP activities in distilled water (DW)-treated or media-treated mock cells were taken as 100%. The results shown are representative of three independent experiments. Mean values are shown with ± s.e. *Po0.05. (e and f) The presence of PTPs in the immunocomplexes used in panels (a) and (b) was confirmed by western blotting using anti-CD45 and anti-SHP1 antibodies for cells treated with H 2 O 2 (e) or TNF-a (f). (g) Mock cells were pretreated with N-acetyl-L-cysteine (NAC) for 1 h, after which they were incubated with cycloheximide (CHX) plus TNF-a for 10 min. The cells were immunoprecipitated with normal IgG or anti-SHP1 antibody at 4 1C for 8 h, after which PTP assays were performed using pNPP as substrate as described in panel (c). The presence of PTPs in the immunocomplexes was confirmed by western blotting using anti-SHP1 antibody. NigG, normal IgG; HC, heavy chain IgG; W, whole cell lysate. restored on thioredoxin ablation (Figure 6e ). Together these data suggest that the antiapoptotic effect of SOCS1 is exerted, at least in part, via thioredoxin.
Suppression of oxidative stress-induced apoptosis signaling by SOCS1 involves a molecular interaction between PTP and thioredoxin We then tested the effect of thioredoxin on the PTP activity regulation by SOCS1. The result in Figure 7a shows that in HA-SOCS1 cells, the protection of SHP1 activity from the ROS attack is lost on thioredoxin ablation, which correlates with the restoration of Jak and p38 activity in these cells (Figure 6e ). This indicates that SHP1-protective effect of SOCS1 in Figure 5 is mediated by thioredoxin. To investigate the mechanism by which thioredoxin regulates SHP1 activities, the molecular interaction between SHP1 and thioredoxin was examined. Coimmunoprecipitation analysis has demonstrated that there is a specific and transiently induced interaction between thioredoxin and SHP1 occurring at 10 min after H 2 O 2 treatment (Figure 7b,  upper panel, lanes 2 vs 3) . Notably, such interaction is constitutively present in SOCS1 overexpressing cells and further enhanced on stimulation with H 2 O 2 (Figure 7b,  upper panel, lanes 5 and 6) . A similar interaction pattern of thioredoxin with SHP1 was also observed on TNF-a treatment, and the pretreatment of NAC resulted in a complete inhibition of the interaction in mock cells, indicating that the interaction is triggered by ROS signal (Figure 7c: upper panel, lanes 2-4) . As compared to mock cells, the molecular interaction of thioredoxin with SHP1 was generally increased in SOCS1 overexpressing cells (Figures 7b and c) , which is probably due to the increased thioredoxin levels in these cells (Figure 6a) . The results suggest that antiapoptotic action of SOCS1 involves the promotion of molecular interaction between PTP and thioredoxin, which may protect PTP from ROS-mediated inactivation.
Discussion
To our knowledge, this is the first study to report that SOCS1 acts as an antiapoptotic factor under oxidative stress and that the antiapoptotic action occurs via mechanisms involving the PTP-thioredoxin system. We found that SOCS1 levels are transiently upregulated in response to apoptosis-inducing oxidative stress such as H 2 O 2 or TNF-a in both primary immune cells and Jurkat T cells (Supplementary Figure S1) , and that 1 1 1.7 2.1 1.8 1.2 1.5 3.3 3.5 3.5 2.8 1 2.1 2.6 1.8 1.6 0.5 0.8 1.5 1.6 1.1 1.6 1.8 1.3 1 1.1 2.2 2.6 3.5 2. The whole extracts were then used for western blots using respective antibodies to analyse the activation of Jak1, Jak2, p38 and caspase 3. Mean values are shown where s.e. are less than 5% of the mean (n ¼ 2).
overexpression of SOCS1 exerted antiapoptotic effects (Figure 1 ). These observations suggest that SOCS1 is induced as a protective response to ROS-generating apoptotic stimuli, representing an intracellular defense mechanism against oxidative stress. Although SOCS3 was also induced by oxidative stress (Supplementary Figure S1) , the oxidant-induced apoptosis was not inhibited in cells transfected with SOCS3 (data not shown), indicating that SOCS proteins exert isoformspecific growth regulatory effects in cells under oxidative stress. The antiapoptotic effect of SOCS1 was also observed against various ROS-inducing and/or DNA damaging agents such as etoposide and hydroxyurea (data not shown).
As an initial signaling event leading to apoptosis, our data demonstrate the activation of Jaks within minutes of H 2 O 2 or TNF-a stimulation in both Jurkat T cells and mouse splenocytes (Figure 3) . Accompanied with Jak activation, the phosphorylation of several Stat members was induced during apoptosis signaling by H 2 O 2 (Supplementary Figure S3) . Although the increased levels of phospho-Stat3 and phospho-Stat1 by H 2 O 2 were downregulated in SOCS1-transduced cells, it seems unlikely that such activated Stats directly function to participate in the initial signaling for apoptosis. It is more likely that the Stats activated by Jaks bind to the SOCS promoter region, which induces the activation of SOCS gene expression .
In line with the established function of p38 in stressinduced signaling and apoptosis (Kim et al., 2006) , we also demonstrate that p38 plays a key role as a downstream mediator of Jaks, leading to apoptosis. Importantly, SOCS1 counteracted the H 2 O 2 -or TNF-ainduced p38 activation by suppressing Jaks, which resulted in an antiapoptotic effect (Figures 3 and 4) . Although p38 activation involves phosphorylation of both threonine and tyrosine residues, a catalytic interaction between Jak tyrosine kinases and p38 is unlikely, as no direct molecular interaction of Jaks with p38 was observed in response to H 2 O 2 (data not shown). Thus, the mechanisms by which Jaks control p38 activity under this condition remain unknown, which requires further investigation.
The ROS-generating oxidative stress is thought to cause PTP inactivation by attacking thiol groups in the catalytic site (Denu and Tanner, 1998) , and Jaks are subject to the regulation by PTPs. Thus we have turned our attention to the role of PTPs in Jak-mediated apoptotic signaling. Among PTPs shown to regulate Jaks, such as CD45, SHP1, SHP2, PTP1B and TCPTP, we chose SHP1 and CD45 to examine the role in T-cell apoptosis, because these are highly expressed by hematopoietic cells including T cells (Penninger et al., 2001) . We found that ROS-induced Jurkat T-cell apoptosis is mediated by PTP, as demonstrated by siRNA knockdown of CD45 and SHP1 (Figures 5a and . Importantly, the PTP assay data clearly indicate that ROS induces downregulation of CD45 and SHP1 activities, and that SOCS1 overexpression protects the PTPs from the inactivation by ROS (Figures 5c and d) . How would SOCS1 protect the PTPs from the ROS attack? It is proposed that ROS induces PTP inactivation by reversible oxidation of thiol groups to form disulfide bonds (Denu and Tanner, 1998) , which are picked up by the redox-sensing proteins such as thioredoxin or glutathione, which restore the PTP activities by reducing oxidized PTPs (Reth, 2002) . In addition to oxidation, S-nitrosylation of PTP has been suggested as a mechanism of PTP inhibition induced by mild oxidative stress (Barrett et al., 2005) . We cannot rule out the possibility that SHP1 or CD45 undergoes Snitrosylation on TNF-a or H 2 O 2 treatment in T cells under the assay conditions employed, which may later proceed to oxidation to sulfenic acid formation. Whatever the oxidative modifications involved, our data demonstrate that the PTP-thioredoxin interaction occurs at the molecular level in an ROS signal-sensitive manner, which is reversed by antioxidant NAC (Figure 7c ). The binding of thioredoxin to SHP1 appears to be dependent on the redox potential of thioredoxin, in that the binding was impaired in cells expressing the active site mutant (C32S/C35S) of thioredoxin which was incapable of PTP protection from ROS-induced inactivation (data not shown).
In control T cell line, the interaction between thioredoxin and PTP is relatively short-lived ( Figure 7b) ; therefore, the failure of persistent protection by thioredoxin would lead to PTP inactivation and subsequent Jak activation. However, in SOCS1 overexpressing T cells, the interaction of PTPs with thioredoxin is enhanced and sustained (Figures 7b and  c) , probably as a result of increased thioredoxin levels (Figures 6a and b) . Thus, the sustained interaction and protection of PTPs against ROS attack by thioredoxin in SOCS1-transfected cells would promote dephosphorylation of Jaks. This blocks the transactivation of Jaks and/or reversibly suppresses Jak action as the mediator of apoptosis. Independently, Jaks phosphorylated in response to ROS signal may be irreversibly inhibited by direct molecular interaction with SOCS1 as shown by immunoprecipitation (Supplementary Figure S6) , which also influences the downstream signaling pathways for apoptosis.
The increased expression of thioredoxin in SOCS1-transduced cells is likely achieved by the transcriptional activation of thioredoxin gene as shown by upregulation of thioredoxin mRNA levels (Supplementary Figure  S5A) . Although specific interactions of SOCS1 with the transcription machinery of thioredoxin gene are not known, role of SOCS proteins as transcriptional factors have been suggested in recent studies (Baetz et al., 2008; Masuhiro et al., 2008) . In particular, SOCS1 is found to interact with proto-oncogene FBI-1 (unpublished observations), which is involved in transcriptional regulation of tumor suppressor Rb as a potential mechanism to promote oncogenic potential (Jeon et al., 2008) . Another possible mechanism of thioredoxin upregulation by SOCS1 is through the control of protein stability by the inhibition of protein degradation. In this regard, we have noted that polyubiquitination of thioredoxin was significantly reduced in SOCS1-transduced cells as compared to mock cells, which was correlated with increased level of thioredoxin (data not shown).
Recently it has been reported that overexpression of SOCS1 induces ubiquitination and degradation of apoptosis signaling-regulating kinase-1 (ASK1) and that thioredoxin associates with the ASK1-SOCS1 complex through ASK1 (He et al., 2006) . The ASK1-thioredoxin complex formation was shown to be regulated by ROS, which in turn determines ASK1 activity leading to ROSinduced apoptosis (Hsieh and Papaconstantinou, 2006) . Therefore, antioxidant thioredoxin and antiapoptotic SOCS1 may regulate the apoptosis-inducing kinase system by a coordinated mechanism. Results from our study also suggest that SOCS1 exerts antiapoptotic function via thioredoxin, which acts in the ROS scavenging system as well as in protection of PTPs.
With respect to the novel antiapoptotic function of SOCS1, the implication of this study on oncogenesis is bifold. For immune cells with oncogenic transformation exposed to ROS by DNA-damaging agents, SOCS1 would counteract the ROS-induced apoptotic cell death, allowing survival and further oncogenesis. On the other hand, SOCS1 may act to protect normal lymphocytes in tumor microenvironment from ROS attack induced by DNA-damaging drugs or ionizing radiation.
In conclusion, our data collectively indicate that SOCS1 acts as an antiapoptotic factor for the oxidative stress-induced response in immune cells, via indirect actions involving ROS regulation and PTP protection by thioredoxin as well as direct interaction of SOCS1 with activated Jaks required for the apoptosis signaling (Figure 8 ). Through the reciprocal regulation of PTPs and Jaks, SOCS1 may play an important role in the control of intracellular redox potential and the associated apoptosis signaling in immune cells under oxidative stress.
Materials and methods
Reagents and antibodies H 2 O 2 was purchased from Sigma-Aldrich (St Louis, MO, USA). Human or mouse recombinant TNF-a was obtained from R&D Systems (Minneapolis, MN, USA). Commercially available sources for antibodies used in this study are described in Supplementary Materials.
Cell lines, treatment and constructs
The human T cell line Jurkat were maintained as described . To induce apoptosis, stable cells were treated with varying concentrations of H 2 O 2 or recombinant TNF-a. Unless otherwise specified, TNF-a treatment throughout the text refers to 10 ng/ml TNF-a treated after 100 mM cycloheximide (CHX; Sigma) pretreatment and washing. The cloning of vectors and procedures for stable cell line construction are described in Supplementary Materials. Figure 8 A model of suppressors of cytokine signaling 1 (SOCS1) action as an antiapoptotic factor on oxidative stress. Reactive oxygen species (ROS) generated by oxidative stress (from tumor necrosis factor (TNF)-a or H 2 O 2 ) inactivate protein tyrosine phosphatases (PTPs: CD45 or SHP1) by thiol oxidation in the catalytic site, which results in the increased activation of Jaks acting upstream of p38 and the subsequent apoptosis. ROS also induces upregulation of SOCS1 expression and thioredoxin levels. Thioredoxin interacts with oxidized SHP1 or CD45 to restore activities through the redox cycle. The sustained PTP activities lead to attenuation of Jaks and p38 to suppress apoptosis. Independently, SOCS1 may directly interact with phosphorylated Jaks induced by ROS to inhibit Jak function by switching off Jak activities or by recruiting ubiquitination machinery.
